RecruitingNCT05750147

The SMARTER Cardiomyopathy Study

Genetics, Imaging and Artificial Intelligence for Precision Care in Cardiomyopathy


Sponsor

Imperial College London

Enrollment

1,000 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Cardiomyopathies are diseases of the heart muscle. Known genetic factors may account for some cardiomyopathy cases but there is still much to understand about the genetic and environmental causes and how the disease progresses. Finding new ways to diagnose and treat cardiomyopathies could improve the health and well-being of patients with these conditions. This study will collect data from individuals with cardiomyopathy or related heart muscle disease, or with a possible genetic predisposition to cardiomyopathy, and follow them over time to observe the progress of their heart and health. This study will collect DNA, blood samples, and detailed clinical \& lifestyle information at the start of the study, and data collected during routine healthcare visits over time. * learn what causes cardiomyopathy, and therefore how to treat it * understand why cardiomyopathy progresses differently in different people, to improve the ability to recognise who will benefit from different treatments at different times The investigators will collaborate with other centres internationally to collect a large of group of participants with similar cardiomyopathies, providing power to identify new pathways that cause disease and ways of predicting which participants are at risk of having more severe disease.


Eligibility

Inclusion Criteria5

  • Adults with the capacity to consent Children with parental/guardian consent Male and Female
  • Meeting the following criteria:
  • Patients with a confirmed diagnosis of cardiomyopathy or related condition
  • Patients with a family member with cardiomyopathy, or a related condition
  • Patients with a genetic variant that may predispose to cardiomyopathy, or a related condition

Exclusion Criteria1

  • Patients without the capacity to provide informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood Sample Collection

Blood for DNA and biomarker analysis


Locations(2)

Guys & St Thomas' NHS Foundation Trust

London, United Kingdom

Kings College Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05750147


Related Trials